ZA815133B - Hypoglycemic 5-substituted oxazolidine-2,4-diones - Google Patents
Hypoglycemic 5-substituted oxazolidine-2,4-dionesInfo
- Publication number
- ZA815133B ZA815133B ZA815133A ZA815133A ZA815133B ZA 815133 B ZA815133 B ZA 815133B ZA 815133 A ZA815133 A ZA 815133A ZA 815133 A ZA815133 A ZA 815133A ZA 815133 B ZA815133 B ZA 815133B
- Authority
- ZA
- South Africa
- Prior art keywords
- diones
- hypoglycemic
- substituted oxazolidine
- oxazolidine
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
- C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
- C07C45/513—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups the singly bound functional group being an etherified hydroxyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17320680A | 1980-07-28 | 1980-07-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA815133B true ZA815133B (en) | 1982-07-28 |
Family
ID=22630977
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA815133A ZA815133B (en) | 1980-07-28 | 1981-07-27 | Hypoglycemic 5-substituted oxazolidine-2,4-diones |
ZA815126A ZA815126B (en) | 1980-07-28 | 1981-07-27 | Hypoglycemic 5-substituted oxazolidine-2,4-diones |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA815126A ZA815126B (en) | 1980-07-28 | 1981-07-27 | Hypoglycemic 5-substituted oxazolidine-2,4-diones |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPS5758676A (xx) |
BE (2) | BE889758A (xx) |
GT (2) | GT198170554A (xx) |
ZA (2) | ZA815133B (xx) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4430337A (en) * | 1982-06-23 | 1984-02-07 | Pfizer Inc. | Alicyclic substituted oxazolidine-2,4-diones having hypoglycemic activity |
US4617312A (en) * | 1983-01-17 | 1986-10-14 | Pfizer Inc. | Aldose reductase inhibiting 5-(2-alkoxyphenyl) thiazolidinediones |
-
1981
- 1981-07-21 GT GT198170554A patent/GT198170554A/es unknown
- 1981-07-21 GT GT198170555A patent/GT198170555A/es unknown
- 1981-07-27 BE BE0/205506A patent/BE889758A/fr not_active IP Right Cessation
- 1981-07-27 ZA ZA815133A patent/ZA815133B/xx unknown
- 1981-07-27 BE BE0/205505A patent/BE889757A/fr not_active IP Right Cessation
- 1981-07-27 JP JP56117569A patent/JPS5758676A/ja active Granted
- 1981-07-27 ZA ZA815126A patent/ZA815126B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
JPS6135188B2 (xx) | 1986-08-12 |
JPS5758676A (en) | 1982-04-08 |
BE889758A (fr) | 1982-01-27 |
GT198170555A (es) | 1983-01-12 |
ZA815126B (en) | 1983-02-23 |
GT198170554A (es) | 1983-01-12 |
BE889757A (fr) | 1982-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2083810B (en) | Hypoglycemic 5-substituted oxazolidine-2,4-diones | |
AU7343581A (en) | Hypoglycemic 5-substituted oxazolidine-2,4-diones | |
GB2080803B (en) | Hypoglycemic 5-substituted oxazolidine-2,4-diones | |
ZA815126B (en) | Hypoglycemic 5-substituted oxazolidine-2,4-diones | |
EP0039920A3 (en) | Triazaloquinoxalin-1,4-diones | |
YU92183A (en) | Process for obtaining hypoglycemic 5-substituted oxazolidine-2,4-diones | |
IE842427L (en) | Intermediates for hypoglycemic oxazolidine-2, 4-diones | |
PH19469A (en) | Intermediates for the preparation of hypoglycemic 5-subatituted oxazolidine-2,4-diones | |
AU555134B2 (en) | Intermediates in the preparation of 5-substituted oxazolidine-2, 4-diones | |
YU92083A (en) | Process for obtaining hypoglycemic 5-substituted oxazolodine 2,4-diones |